Search results
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 23 hours agoAtea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases ...
Merus reports promising results for lung cancer antibody MCLA-129 By Investing.com
Investing.com· 3 days agoMerus N.V. (NASDAQ:MRUS), a clinical-stage oncology company, has shared new data on its...
Dosing Continues in Lexaria’s Second GLP-1 Human Pilot Study
Digital Journal· 21 hours agoSecond study arm dosing is now complete. KELOWNA, BC / ACCESSWIRE / June 5, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug ...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 4 days agoLive from ASCO 2024 | Ascentage Pharma Releases Updated Data of FAK/ALK/ROS1 Inhibitor APG-2449 in Patients with NSCLC PR Newswire SUZHOU, China, and ROCKVILLE, Md., June 1, 2024 SUZHOU, China ...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 1 day agoLive from ASCO 2024 | Oral Report Released Latest Data of Olverembatinib in SDH-Deficient GIST, Including a CBR of 92.3% PR Newswire SUZHOU, China and ROCKVILLE, Md., June 4, 2024 SUZHOU, China ...
Bio-Thera Solutions Presents Clinical Data for BAT8006 (Folate Receptor-alpha-ADC) at the 2024...
The Woonsocket Call· 4 days agoBio-Thera Solutions Inc. (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of innovative therapies and biosimilars, will present a poster at the 2024 ASCO Annual ...
Summer's in the air, and so are fireworks. What's allowed in Akron-area communities?
Akron Beacon Journal· 3 days agoOnly some types of fireworks can be set off without a license. With summertime celebrations already in full swing in Northeast Ohio, some residents may be looking forward to setting off fireworks ...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 4 days agoLive from ASCO 2024 | Ascentage Pharma Releases Updated Data of FAK/ALK/ROS1 Inhibitor APG-2449 in Patients with NSCLC PR Newswire SUZHOU, China, and ROCKVILLE, Md., June 1, 2024 SUZHOU, China ...
Small Business - Salisbury Post | Salisbury Post
The Salisbury Post· 3 days agoUTRECHT, The Netherlands and CAMBRIDGE, Mass., June 03, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics